<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39329758</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>27</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>29</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2073-4409</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>18</Issue><PubDate><Year>2024</Year><Month>Sep</Month><Day>19</Day></PubDate></JournalIssue><Title>Cells</Title><ISOAbbreviation>Cells</ISOAbbreviation></Journal><ArticleTitle>Sulfated Bile Acids in Serum as Potential Biomarkers of Disease Severity and Mortality in COVID-19.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1576</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/cells13181576</ELocationID><Abstract><AbstractText>The fight against coronavirus disease 2019 (COVID-19) continues. Since the pandemic's onset, several biomarkers have been proposed to assess the diagnosis and prognosis of this disease. This research aimed to identify potential disease severity biomarkers in serum samples of patients with COVID-19 during the disease course. Data were collected using untargeted and targeted mass spectrometry methods. The results were interpreted by performing univariate and multivariate analyses. Important metabolite classes were identified by qualitative untargeted metabolomics in 15 serum samples from survivors of COVID-19. Quantitative targeted metabolomics on a larger patient cohort including 15 non-survivors confirmed serum 3-sulfate bile acids (i.e. GLCA-3S) were significantly increased in non-survivors compared to survivors during the early disease stage (<i>p</i>-value &lt; 0.0001). Notably, it was associated with a higher risk of mortality (odds ratio of 26). A principal component analysis showed the ability to discriminate between survivors and non-survivors using the BA concentrations. Furthermore, increased BA-S is highly correlated with known parameters altered in severe clinical conditions.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Porru</LastName><ForeName>Emanuele</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0001-8041-1085</Identifier><AffiliationInfo><Affiliation>Occupational Medicine Unit, Department of Medical and Surgical Sciences, Alma Mater Studiorum, University of Bologna, 40138 Bologna, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Comito</LastName><ForeName>Rossana</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Division of Occupational Medicine, "IRCCS" Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Interino</LastName><ForeName>Nicolò</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Laboratorio di Proteomica Metabolomica e Chimica Bioanalitica, "IRCCS" Istituto delle Scienze Neurologiche di Bologna, 40139 Bologna, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cerrato</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-6625-8782</Identifier><AffiliationInfo><Affiliation>Department of Chemistry, "Sapienza" University of Rome, 00185 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Contoli</LastName><ForeName>Marco</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Respiratory Section, Department of Morphology, Surgery, and Experimental Medicine, University of Ferrara, 44121 Ferrara, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rizzo</LastName><ForeName>Paola</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0001-7174-9674</Identifier><AffiliationInfo><Affiliation>Laboratory for Technologies of Advanced Therapies "LTTA", Department of Translaqutional Medicine, University of Ferrara, 44121 Ferrara, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Maria Cecilia Hospital, GVM Care &amp; Research, 48022 Cotignola, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Conti</LastName><ForeName>Matteo</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-1579-9674</Identifier><AffiliationInfo><Affiliation>Local Unit of Imola, Department of Public Health, Health Service of the Emilia-Romagna Region, 40026 Imola, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Campo</LastName><ForeName>Gianluca</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0002-5150-188X</Identifier><AffiliationInfo><Affiliation>Cardiovascular Institute, Azienda Ospedaliero, University of Ferrara, 44124 Ferrara, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Spadaro</LastName><ForeName>Savino</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-5027-5318</Identifier><AffiliationInfo><Affiliation>Intensive Care Unit, Department of Morphology, Surgery, and Experimental Medicine, University of Ferrara, 44121 Ferrara, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Caliceti</LastName><ForeName>Cristiana</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-6740-5331</Identifier><AffiliationInfo><Affiliation>Department of Biomedical and Neuromotor Sciences, Alma Mater Studiorum, University of Bologna, 40123 Bologna, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Biostructures and Biosystems National Institute "INBB", 00136 Rome, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Interdepartmental Centre for Industrial Agrofood Research-CIRI Agrofood, University of Bologna, 47521 Cesena, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Interdepartmental Center of Industrial Research "CIRI"-Energy and Environment, Alma Mater Studiorum, University of Bologna, 40126 Bologna, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marini</LastName><ForeName>Federico</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0001-8266-1117</Identifier><AffiliationInfo><Affiliation>Department of Chemistry, "Sapienza" University of Rome, 00185 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Capriotti</LastName><ForeName>Anna L</ForeName><Initials>AL</Initials><AffiliationInfo><Affiliation>Department of Chemistry, "Sapienza" University of Rome, 00185 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Laganà</LastName><ForeName>Aldo</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-4963-3020</Identifier><AffiliationInfo><Affiliation>Department of Chemistry, "Sapienza" University of Rome, 00185 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roda</LastName><ForeName>Aldo</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-7649-4797</Identifier><AffiliationInfo><Affiliation>Biostructures and Biosystems National Institute "INBB", 00136 Rome, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Chemistry "G. Ciamician", Alma Mater Studiorum, University of Bologna, 40126 Bologna, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>PRIN 2017 (Project 2017Y2PAB8)</GrantID><Agency>Ministry of Education, University and Research of Italy</Agency><Country /></Grant><Grant><GrantID>Project Epic-XS (Project 823839)</GrantID><Agency>EU Horizon 2020 program INFRAIA</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Cells</MedlineTA><NlmUniqueID>101600052</NlmUniqueID><ISSNLinking>2073-4409</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001647">Bile Acids and Salts</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="Y">Biomarkers</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001647" MajorTopicYN="Y">Bile Acids and Salts</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="Y">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055432" MajorTopicYN="N">Metabolomics</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D025341" MajorTopicYN="N">Principal Component Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">bile acids</Keyword><Keyword MajorTopicYN="N">early severity biomarker</Keyword><Keyword MajorTopicYN="N">targeted metabolomics</Keyword><Keyword MajorTopicYN="N">untargeted metabolomics</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>8</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>9</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>27</Day><Hour>16</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>27</Day><Hour>16</Hour><Minute>17</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>27</Day><Hour>9</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>19</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39329758</ArticleId><ArticleId IdType="pmc">PMC11430696</ArticleId><ArticleId IdType="doi">10.3390/cells13181576</ArticleId><ArticleId IdType="pii">cells13181576</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Li X., To K.K. Biomarkers for severe COVID-19. EBioMedicine. 2021;68:103405. doi: 10.1016/j.ebiom.2021.103405.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2021.103405</ArticleId><ArticleId IdType="pmc">PMC8146475</ArticleId><ArticleId IdType="pubmed">34049243</ArticleId></ArticleIdList></Reference><Reference><Citation>Tjendra Y., Al Mana A.F., Espejo A.P., Akgun Y., Millan N.C., Gomez-Fernandez C., Cray C. Predicting Disease Severity and Outcome in COVID-19 Patients: A Review of Multiple Biomarkers. Arch. Pathol. Lab. Med. 2020;144:1465–1474. doi: 10.5858/arpa.2020-0471-SA.</Citation><ArticleIdList><ArticleId IdType="doi">10.5858/arpa.2020-0471-SA</ArticleId><ArticleId IdType="pubmed">32818235</ArticleId></ArticleIdList></Reference><Reference><Citation>Hottz E.D., Azevedo-Quintanilha I.G., Palhinha L., Teixeira L., Barreto E.A., Pão C.R.R., Righy C., Franco S., Souza T.M.L., Kurtz P., et al. Platelet activation and platelet-monocyte aggregate formation trigger tissue factor expression in patients with severe COVID-19. Blood. 2020;136:1330–1341. doi: 10.1182/blood.2020007252.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood.2020007252</ArticleId><ArticleId IdType="pmc">PMC7483437</ArticleId><ArticleId IdType="pubmed">32678428</ArticleId></ArticleIdList></Reference><Reference><Citation>Contoli M., Papi A., Tomassetti L., Rizzo P., Sega F.V.D., Fortini F., Torsani F., Morandi L., Ronzoni L., Zucchetti O., et al. Blood Interferon-α Levels and Severity, Outcomes, and Inflammatory Profiles in Hospitalized COVID-19 Patients. Front. Immunol. 2021;12:648004. doi: 10.3389/fimmu.2021.648004.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.648004</ArticleId><ArticleId IdType="pmc">PMC7985458</ArticleId><ArticleId IdType="pubmed">33767713</ArticleId></ArticleIdList></Reference><Reference><Citation>Kimura-Ohba S., Asaka M.N., Utsumi D., Takabatake Y., Takahashi A., Yasutomi Y., Isaka Y., Kimura T. d-Alanine as a biomarker and a therapeutic option for severe influenza virus infection and COVID-19. Biochim. Biophys. Acta (BBA)—Mol. Basis Dis. 2022;1869:166584. doi: 10.1016/j.bbadis.2022.166584.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbadis.2022.166584</ArticleId><ArticleId IdType="pmc">PMC9584837</ArticleId><ArticleId IdType="pubmed">36280155</ArticleId></ArticleIdList></Reference><Reference><Citation>Khalaji A., Amirkhani N., Sharifkashani S., Peiman S., Behnoush A.H. Systematic Review of Endocan as a Potential Biomarker of COVID-19. Angiology. 2023;75:107–115. doi: 10.1177/00033197231152941.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/00033197231152941</ArticleId><ArticleId IdType="pmc">PMC9895317</ArticleId><ArticleId IdType="pubmed">36680504</ArticleId></ArticleIdList></Reference><Reference><Citation>Park M., Hur M., Kim H., Lee C.H., Lee J.H., Kim H.W., Nam M., Lee S. Soluble ST2 as a Useful Biomarker for Predicting Clinical Outcomes in Hospitalized COVID-19 Patients. Diagnostics. 2023;13:259. doi: 10.3390/diagnostics13020259.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/diagnostics13020259</ArticleId><ArticleId IdType="pmc">PMC9857572</ArticleId><ArticleId IdType="pubmed">36673069</ArticleId></ArticleIdList></Reference><Reference><Citation>Frischbutter S., Durek P., Witkowski M., Angermair S., Treskatsch S., Maurer M., Radbruch A., Mashreghi M. Serum TGF-β as a predictive biomarker for severe disease and fatality of COVID-19. Eur. J. Immunol. 2023;53:e2350433. doi: 10.1002/eji.202350433.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/eji.202350433</ArticleId><ArticleId IdType="pubmed">37386908</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar A., Karn E., Trivedi K., Kumar P., Chauhan G., Kumari A., Pant P., Munisamy M., Prakash J., Sarkar P.G., et al. Procalcitonin as a predictive marker in COVID-19: A systematic review and meta-analysis. PLOS ONE. 2022;17:e0272840. doi: 10.1371/journal.pone.0272840.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0272840</ArticleId><ArticleId IdType="pmc">PMC9462680</ArticleId><ArticleId IdType="pubmed">36084093</ArticleId></ArticleIdList></Reference><Reference><Citation>Spadaro S., Fogagnolo A., Campo G., Zucchetti O., Verri M., Ottaviani I., Tunstall T., Grasso S., Scaramuzzo V., Murgolo F., et al. Markers of endothelial and epithelial pulmonary injury in mechanically ventilated COVID-19 ICU patients. Crit. Care. 2021;25:74. doi: 10.1186/s13054-021-03499-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-021-03499-4</ArticleId><ArticleId IdType="pmc">PMC7894238</ArticleId><ArticleId IdType="pubmed">33608030</ArticleId></ArticleIdList></Reference><Reference><Citation>Sega F.V.D., Fortini F., Spadaro S., Ronzoni L., Zucchetti O., Manfrini M., Mikus E., Fogagnolo A., Torsani F., Pavasini R., et al. Time course of endothelial dysfunction markers and mortality in COVID-19 patients: A pilot study. Clin. Transl. Med. 2021;11:e283. doi: 10.1002/ctm2.283.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ctm2.283</ArticleId><ArticleId IdType="pmc">PMC7919132</ArticleId><ArticleId IdType="pubmed">33784001</ArticleId></ArticleIdList></Reference><Reference><Citation>Wan Y.-J.Y., Sheng L. Regulation of bile acid receptor activity. Liver Res. 2018;2:180–185. doi: 10.1016/j.livres.2018.09.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.livres.2018.09.008</ArticleId><ArticleId IdType="pmc">PMC7147511</ArticleId><ArticleId IdType="pubmed">32280557</ArticleId></ArticleIdList></Reference><Reference><Citation>Franco P., Porru E., Fiori J., Gioiello A., Cerra B., Roda G., Caliceti C., Simoni P., Roda A. Identification and quantification of oxo-bile acids in human faeces with liquid chromatography–mass spectrometry: A potent tool for human gut acidic sterolbiome studies. J. Chromatogr. A. 2018;1585:70–81. doi: 10.1016/j.chroma.2018.11.038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chroma.2018.11.038</ArticleId><ArticleId IdType="pubmed">30482431</ArticleId></ArticleIdList></Reference><Reference><Citation>Bathena S.P.R., Mukherjee S., Olivera M., Alnouti Y. The profile of bile acids and their sulfate metabolites in human urine and serum. J. Chromatogr. B. 2013;942-943:53–62. doi: 10.1016/j.jchromb.2013.10.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jchromb.2013.10.019</ArticleId><ArticleId IdType="pubmed">24212143</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischer S., Beuers U., Spengler U., Zwiebel F.M., Koebe H.-G. Hepatic levels of bile acids in end-stage chronic cholestatic liver disease. Clin. Chim. Acta. 1996;251:173–186. doi: 10.1016/0009-8981(96)06305-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0009-8981(96)06305-X</ArticleId><ArticleId IdType="pubmed">8862472</ArticleId></ArticleIdList></Reference><Reference><Citation>Kato T., Yoneda M., Nakamura K., Makino I. Enzymatic determination of serum 3α-sulfated bile acids concentration with bile acid 3α-sulfate sulfohydrolase. Dig. Dis. Sci. 1996;41:1564–1570. doi: 10.1007/BF02087901.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF02087901</ArticleId><ArticleId IdType="pubmed">8769280</ArticleId></ArticleIdList></Reference><Reference><Citation>Takikawa H., Otsuka H., Beppu T., Seyama Y., Yamakawa T. Serum Concentrations of Bile Acid Glucuronides in Hepatobiliary Diseases. Digestion. 1983;27:189–195. doi: 10.1159/000198952.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000198952</ArticleId><ArticleId IdType="pubmed">6653918</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu J., Yu M., Xu W., Yu S. Research Progress of Bile Acids in Cancer. Front. Oncol. 2022;11:778258. doi: 10.3389/fonc.2021.778258.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fonc.2021.778258</ArticleId><ArticleId IdType="pmc">PMC8810494</ArticleId><ArticleId IdType="pubmed">35127481</ArticleId></ArticleIdList></Reference><Reference><Citation>Castañé H., Iftimie S., Baiges-Gaya G., Rodríguez-Tomàs E., Jiménez-Franco A., López-Azcona A.F., Garrido P., Castro A., Camps J., Joven J. Machine learning and semi-targeted lipidomics identify distinct serum lipid signatures in hospitalized COVID-19-positive and COVID-19-negative patients. Metabolism. 2022;131:155197. doi: 10.1016/j.metabol.2022.155197.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.metabol.2022.155197</ArticleId><ArticleId IdType="pmc">PMC8976580</ArticleId><ArticleId IdType="pubmed">35381232</ArticleId></ArticleIdList></Reference><Reference><Citation>Escarcega R.D., Honarpisheh P., Colpo G.D., Ahnstedt H.W., Couture L., Juneja S., Torres G., Ortiz G.J., Sollome J., Tabor N., et al. Sex differences in global metabolomic profiles of COVID-19 patients. Cell Death Dis. 2022;13:461. doi: 10.1038/s41419-022-04861-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-022-04861-2</ArticleId><ArticleId IdType="pmc">PMC9106988</ArticleId><ArticleId IdType="pubmed">35568706</ArticleId></ArticleIdList></Reference><Reference><Citation>Piñol-Jiménez F.N., Paz V.C.-D., Ruiz-Torres J.F., Montero-González T., A Urgellés-Carreras S., Breto-García A., Amador-Armenteros A., Llerena-Mesa M.M., Galarraga-Lazcano A.G. High Levels of Serum Bile Acids in COVID-19 Patients on Hospital Admission. MEDICC Rev. 2022;24:53–56. doi: 10.37757/mr2022.v24.n3-4.8.</Citation><ArticleIdList><ArticleId IdType="doi">10.37757/mr2022.v24.n3-4.8</ArticleId><ArticleId IdType="pubmed">36417335</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H., Yan D., Li Y., Gong Y., Mai Y., Li B., Zhu X., Wan X., Xie L., Jiang H., et al. Clinical and antibody characteristics reveal diverse signatures of severe and non-severe SARS-CoV-2 patients. Infect. Dis. Poverty. 2022;11:15. doi: 10.1186/s40249-022-00940-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40249-022-00940-w</ArticleId><ArticleId IdType="pmc">PMC8809634</ArticleId><ArticleId IdType="pubmed">35109926</ArticleId></ArticleIdList></Reference><Reference><Citation>Minato K., Suzuki M., Nagao H., Suzuki R., Ochiai H. Development of analytical method for simultaneous determination of five rodent unique bile acids in rat plasma using ultra-performance liquid chromatography coupled with time-of-flight mass spectrometry. J. Chromatogr. B. 2015;1002:399–410. doi: 10.1016/j.jchromb.2015.08.047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jchromb.2015.08.047</ArticleId><ArticleId IdType="pubmed">26363851</ArticleId></ArticleIdList></Reference><Reference><Citation>Roda G., Porru E., Katsanos K., Skamnelos A., Kyriakidi K., Fiorino G., Christodoulou D., Danese S., Roda A. Serum Bile Acids Profiling in Inflammatory Bowel Disease Patients Treated with Anti-TNFs. Cells. 2019;8:817. doi: 10.3390/cells8080817.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells8080817</ArticleId><ArticleId IdType="pmc">PMC6721523</ArticleId><ArticleId IdType="pubmed">31382518</ArticleId></ArticleIdList></Reference><Reference><Citation>Campo G., Contoli M., Fogagnolo A., Sega F.V.D., Zucchetti O., Ronzoni L., Verri M., Fortini F., Pavasini R., Morandi L., et al. Over time relationship between platelet reactivity, myocardial injury and mortality in patients with SARS-CoV-2-associated respiratory failure. Platelets. 2020;32:560–567. doi: 10.1080/09537104.2020.1852543.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/09537104.2020.1852543</ArticleId><ArticleId IdType="pmc">PMC7754923</ArticleId><ArticleId IdType="pubmed">33270471</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan L., Wang Q., Zhang D., Ding J., Huang Q., Tang Y.-Q., Wang Q., Miao H. Lymphopenia predicts disease severity of COVID-19: A descriptive and predictive study. Signal Transduct. Target. Ther. 2020;5:61. doi: 10.1038/s41392-020-0148-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-020-0148-4</ArticleId><ArticleId IdType="pmc">PMC7189020</ArticleId><ArticleId IdType="pubmed">32377400</ArticleId></ArticleIdList></Reference><Reference><Citation>Minasyan H. Sepsis and septic shock: Pathogenesis and treatment perspectives. J. Crit. Care. 2017;40:229–242. doi: 10.1016/j.jcrc.2017.04.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcrc.2017.04.015</ArticleId><ArticleId IdType="pubmed">28448952</ArticleId></ArticleIdList></Reference><Reference><Citation>Patil M., Singh S., Henderson J., Krishnamurthy P. Mechanisms of COVID-19-induced cardiovascular disease: Is sepsis or exosome the missing link? J. Cell. Physiol. 2020;236:3366–3382. doi: 10.1002/jcp.30109.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcp.30109</ArticleId><ArticleId IdType="pmc">PMC7920909</ArticleId><ArticleId IdType="pubmed">33078408</ArticleId></ArticleIdList></Reference><Reference><Citation>Bautista-Vargas M., Bonilla-Abadía F., Cañas C.A. Potential role for tissue factor in the pathogenesis of hypercoagulability associated with in COVID-19. J. Thromb. Thrombolysis. 2020;50:479–483. doi: 10.1007/s11239-020-02172-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11239-020-02172-x</ArticleId><ArticleId IdType="pmc">PMC7282470</ArticleId><ArticleId IdType="pubmed">32519164</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu N., Chen X., Cai T., Wu L., Xiang Y., Zhang M., Li Y., Song Z., Zhong L. Association of Inflammatory and Hemostatic Markers With Stroke and Thromboembolic Events in Atrial Fibrillation: A Systematic Review and Meta-analysis. Can. J. Cardiol. 2014;31:278–286. doi: 10.1016/j.cjca.2014.12.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cjca.2014.12.002</ArticleId><ArticleId IdType="pubmed">25746020</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaughan D.E. PAI-1 and atherothrombosis. J. Thromb. Haemost. 2005;3:1879–1883. doi: 10.1111/j.1538-7836.2005.01420.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1538-7836.2005.01420.x</ArticleId><ArticleId IdType="pubmed">16102055</ArticleId></ArticleIdList></Reference><Reference><Citation>Willeit K., Pechlaner R., Willeit P., Skroblin P., Paulweber B., Schernthaner C., Toell T., Egger G., Weger S., Oberhollenzer M., et al. Association Between Vascular Cell Adhesion Molecule 1 and Atrial Fibrillation. JAMA Cardiol. 2017;2:516–523. doi: 10.1001/jamacardio.2017.0064.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2017.0064</ArticleId><ArticleId IdType="pmc">PMC5814989</ArticleId><ArticleId IdType="pubmed">28355442</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersen L.W., Mackenhauer J., Roberts J.C., Berg K.M., Cocchi M.N., Donnino M.W. Etiology and Therapeutic Approach to Elevated Lactate Levels. Mayo Clin. Proc. 2013;88:1127–1140. doi: 10.1016/j.mayocp.2013.06.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mayocp.2013.06.012</ArticleId><ArticleId IdType="pmc">PMC3975915</ArticleId><ArticleId IdType="pubmed">24079682</ArticleId></ArticleIdList></Reference><Reference><Citation>Tezcan M., Gokce G.D., Sen N., Kaymak N.Z., Ozer R. Baseline electrolyte abnormalities would be related to poor prognosis in hospitalized coronavirus disease 2019 patients. New Microbes New Infect. 2020;37:100753. doi: 10.1016/j.nmni.2020.100753.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nmni.2020.100753</ArticleId><ArticleId IdType="pmc">PMC7462442</ArticleId><ArticleId IdType="pubmed">32904987</ArticleId></ArticleIdList></Reference><Reference><Citation>Lippi G., South A.M., Henry B.M. Electrolyte imbalances in patients with severe coronavirus disease 2019 (COVID-19) Ann. Clin. Biochem. Int. J. Biochem. Lab. Med. 2020;57:262–265. doi: 10.1177/0004563220922255.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0004563220922255</ArticleId><ArticleId IdType="pmc">PMC8173320</ArticleId><ArticleId IdType="pubmed">32266828</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarvazad H., Cahngaripour S., Roozbahani N.E., Izadi B. Evaluation of electrolyte status of sodium, potassium and magnesium, and fasting blood sugar at the initial admission of individuals with COVID-19 without underlying disease in Golestan Hospital, Kermanshah. New Microbes New Infect. 2020;38:100807. doi: 10.1016/j.nmni.2020.100807.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nmni.2020.100807</ArticleId><ArticleId IdType="pmc">PMC7701326</ArticleId><ArticleId IdType="pubmed">33294198</ArticleId></ArticleIdList></Reference><Reference><Citation>De Carvalho H., Richard M.C., Chouihed T., Goffinet N., Le Bastard Q., Freund Y., Kratz A., Dubroux M., Masson D., Figueres L., et al. Electrolyte imbalance in COVID-19 patients admitted to the Emergency Department: A case–control study. Intern. Emerg. Med. 2021;16:1945–1950. doi: 10.1007/s11739-021-02632-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11739-021-02632-z</ArticleId><ArticleId IdType="pmc">PMC7823192</ArticleId><ArticleId IdType="pubmed">33484453</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Y., Hou B., Liu J., Chen Y., Zhong P. Risk Factors Associated With Long-Term Hospitalization in Patients With COVID-19: A Single-Centered, Retrospective Study. Front. Med. 2020;7:315. doi: 10.3389/fmed.2020.00315.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2020.00315</ArticleId><ArticleId IdType="pmc">PMC7296106</ArticleId><ArticleId IdType="pubmed">32582749</ArticleId></ArticleIdList></Reference><Reference><Citation>Alonso A., Yu B., Qureshi W.T., Grams M.E., Selvin E., Soliman E.Z., Loehr L.R., Chen L.Y., Agarwal S.K., Alexander D., et al. Metabolomics and Incidence of Atrial Fibrillation in African Americans: The Atherosclerosis Risk in Communities (ARIC) Study. PLOS ONE. 2015;10:e0142610. doi: 10.1371/journal.pone.0142610.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0142610</ArticleId><ArticleId IdType="pmc">PMC4636390</ArticleId><ArticleId IdType="pubmed">26544570</ArticleId></ArticleIdList></Reference><Reference><Citation>Hui D.S., Azhar E.I., Madani T.A., Ntoumi F., Kock R., Dar O., Ippolito G., McHugh T.D., Memish Z.A., Drosten C., et al. The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health—The latest 2019 novel coronavirus outbreak in Wuhan, China. Int. J. Infect. Dis. IJID Off. Publ. Int. Soc. Infect. Dis. 2020;91:264–266. doi: 10.1016/j.ijid.2020.01.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2020.01.009</ArticleId><ArticleId IdType="pmc">PMC7128332</ArticleId><ArticleId IdType="pubmed">31953166</ArticleId></ArticleIdList></Reference><Reference><Citation>Perschinka F., Mayerhöfer T., Lehner G.F., Hasslacher J., Klein S.J., Joannidis M. Immunologic response in bacterial sepsis is different from that in COVID-19 sepsis. Infection. 2022;50:1035–1037. doi: 10.1007/s15010-022-01803-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15010-022-01803-0</ArticleId><ArticleId IdType="pmc">PMC8932087</ArticleId><ArticleId IdType="pubmed">35304695</ArticleId></ArticleIdList></Reference><Reference><Citation>Seymour C.W., Yende S., Scott M.J., Pribis J., Mohney R.P., Bell L.N., Chen Y.-F., Zuckerbraun B.S., Bigbee W.L., Yealy D.M., et al. Metabolomics in pneumonia and sepsis: An analysis of the GenIMS cohort study. Intensiv. Care Med. 2013;39:1423–1434. doi: 10.1007/s00134-013-2935-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-013-2935-7</ArticleId><ArticleId IdType="pmc">PMC3932707</ArticleId><ArticleId IdType="pubmed">23673400</ArticleId></ArticleIdList></Reference><Reference><Citation>Fajnzylber J., Regan J., Coxen K., Corry H., Wong C., Rosenthal A., Worrall D., Giguel F., Piechocka-Trocha A., Atyeo C., et al. SARS-CoV-2 viral load is associated with increased disease severity and mortality. Nat. Commun. 2020;11:5493. doi: 10.1038/s41467-020-19057-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-19057-5</ArticleId><ArticleId IdType="pmc">PMC7603483</ArticleId><ArticleId IdType="pubmed">33127906</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu W., Du J., Wei T.-T., Chen L.-Y., Yang X.-X., Bo T., Liu H.-Y., Xie M.-Z., Zhao T.-S., Yang J.-L., et al. Alterations in bile acids as metabolic signatures in the patients with human adenovirus type 7 infection. Front. Med. 2022;9:896409. doi: 10.3389/fmed.2022.896409.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2022.896409</ArticleId><ArticleId IdType="pmc">PMC9489940</ArticleId><ArticleId IdType="pubmed">36160124</ArticleId></ArticleIdList></Reference><Reference><Citation>Duboc H., Rajca S., Rainteau D., Benarous D., Maubert M.-A., Quervain E., Thomas G., Barbu V., Humbert L., Despras G., et al. Connecting dysbiosis, bile-acid dysmetabolism and gut inflammation in inflammatory bowel diseases. Gut. 2012;62:531–539. doi: 10.1136/gutjnl-2012-302578.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2012-302578</ArticleId><ArticleId IdType="pubmed">22993202</ArticleId></ArticleIdList></Reference><Reference><Citation>Farshidfar F., Koleini N., Ardehali H. Cardiovascular complications of COVID-19. J. Clin. Investig. 2021;6 doi: 10.1172/jci.insight.148980.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.148980</ArticleId><ArticleId IdType="pmc">PMC8410051</ArticleId><ArticleId IdType="pubmed">34061779</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J., Choy K.W., Lim H.Y., Ho P. Laboratory markers of severity across three COVID-19 outbreaks in Australia: Has Omicron and vaccinations changed disease presentation? Intern. Emerg. Med. 2022;18:43–52. doi: 10.1007/s11739-022-03081-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11739-022-03081-y</ArticleId><ArticleId IdType="pmc">PMC9472718</ArticleId><ArticleId IdType="pubmed">36103084</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>